Cargando…

Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis

Autoimmune hepatitis (AIH) is an inflammatory liver disease caused by a dysregulated immune response. Although the pathogenesis of AIH remains unclear, impaired regulatory T cells (Tregs) have been considered a driver of AIH development. Unlike autoreactive T cells, Tregs mainly utilize oxidative ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chen, Shen, Yi, Shen, Mengyi, Fan, Xiaoli, Men, Ruoting, Ye, Tinghong, Yang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438122/ https://www.ncbi.nlm.nih.gov/pubmed/34531750 http://dx.doi.org/10.3389/fphar.2021.726128

Ejemplares similares

Methylprednisolone Decreases Mitochondria-Mediated Apoptosis and Autophagy Dysfunction in Hepatocytes of Experimental Autoimmune Hepatitis Model via the Akt/mTOR Signaling
por: Fan, Xiaoli, et al.
Publicado: (2019)

Roles of Macrophages and Exosomes in Liver Diseases
por: Shen, Mengyi, et al.
Publicado: (2020)

Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation
por: Fan, Xiaoli, et al.
Publicado: (2020)

NUDT15 Polymorphism Confer Increased Susceptibility to Thiopurine-Induced Leukopenia in Patients With Autoimmune Hepatitis and Related Cirrhosis
por: Fan, Xiaoli, et al.
Publicado: (2019)

Long Noncoding RNA and Circular RNA Expression Profiles of Monocyte-Derived Dendritic Cells in Autoimmune Hepatitis
por: Yang, Fan, et al.
Publicado: (2021)

Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation
por: Shen, Yi, et al.
Publicado: (2018)

Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy
por: Fan, Zihao, et al.
Publicado: (2022)

Metabolic heterogeneity caused by HLA-DRB1*04:05 and protective effect of inosine on autoimmune hepatitis
por: Yang, Fan, et al.
Publicado: (2022)

Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis
por: Ni, Ping, et al.
Publicado: (2019)

Adenine Nucleotides Attenuate Murine T Cell Activation Induced by Concanavalin A or T Cell Receptor Stimulation
por: Shinohara, Yuria, et al.
Publicado: (2018)

Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
por: Qin, Hanjiao, et al.
Publicado: (2023)

Ethyl Pyruvate Pretreatment Attenuates Concanavalin A-Induced Autoimmune Hepatitis in Mice
por: Shen, Miao, et al.
Publicado: (2014)

Factors and cytokine signatures associated with the response to therapy in patients with primary biliary cholangitis-autoimmune hepatitis overlap syndrome: a real-world study
por: Fan, Xiaoli, et al.
Publicado: (2023)

Metabolic reprogramming of pulmonary fibrosis
por: Li, Jiaxin, et al.
Publicado: (2022)

Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
por: Wang, Mengdi, et al.
Publicado: (2022)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
por: Pi, Aiwen, et al.
Publicado: (2021)

Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis
por: Cheng, Ping, et al.
Publicado: (2014)

Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis
por: Ma, Ying, et al.
Publicado: (2021)

Protective Effects of Necrostatin-1 against Concanavalin A-Induced Acute Hepatic Injury in Mice
por: Zhou, Yingqun, et al.
Publicado: (2013)

Uracil restores susceptibility of methicillin-resistant Staphylococcus aureus to aminoglycosides through metabolic reprogramming
por: Fan, Lvyuan, et al.
Publicado: (2023)

Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice
por: Wang, Chengfen, et al.
Publicado: (2015)

Derangements of liver tissue bioenergetics in Concanavalin A-induced hepatitis
por: Al-Shamsi, Mariam, et al.
Publicado: (2013)

Protective effect of galangin in Concanavalin A-induced hepatitis in mice
por: Luo, Qingqiong, et al.
Publicado: (2015)

GIT2 deficiency attenuates concanavalin A-induced hepatitis in mice
por: Hao, Yu-E, et al.
Publicado: (2015)

Propofol inhibits neuroinflammation and metabolic reprogramming in microglia in vitro and in vivo
por: Guan, Shuyuan, et al.
Publicado: (2023)

The role of metabolic reprogramming in pancreatic cancer chemoresistance
por: Liu, Chang, et al.
Publicado: (2023)

The Protective Effect of Resveratrol on Concanavalin-A-Induced Acute Hepatic Injury in Mice
por: Zhou, Yingqun, et al.
Publicado: (2015)

Hepatoprotective Effect of Mixture of Dipropyl Polysulfides in Concanavalin A-Induced Hepatitis
por: Arsenijevic, Dragana, et al.
Publicado: (2021)

Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A
por: Wan, Y., et al.
Publicado: (2014)

Protective effects of mitochondrial fission inhibition on ox-LDL induced VSMC foaming via metabolic reprogramming
por: Fang, Yijin, et al.
Publicado: (2022)

Preventive Effect of Halofuginone on Concanavalin A-Induced Liver Fibrosis
por: Liang, Jie, et al.
Publicado: (2013)

Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice
por: Mao, Yuqing, et al.
Publicado: (2015)

Concanavalin A-induced autoimmune hepatitis model in mice: Mechanisms and future outlook
por: Liu, Yang, et al.
Publicado: (2022)

Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
por: Yang, Wenchang, et al.
Publicado: (2022)

Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming
por: Chen, Hao, et al.
Publicado: (2023)

Aqueous extract of Amydrium sinense (Engl.) H. Li alleviates hepatic fibrosis by suppressing hepatic stellate cell activation through inhibiting Stat3 signaling
por: Li, Jingyan, et al.
Publicado: (2023)

Autoimmune Hepatitis with Elevated Serum IgG4 Levels Have a High Prevalence of Cirrhosis at Diagnosis
por: Xue, Mei, et al.
Publicado: (2021)

Efficacy and Safety of Immunosuppressive Therapy for PBC–AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study
por: Fan, Xiaoli, et al.
Publicado: (2018)

Breviscapine remodels myocardial glucose and lipid metabolism by regulating serotonin to alleviate doxorubicin-induced cardiotoxicity
por: Li, Meng-Jiao, et al.
Publicado: (2022)

Baicalein Selectively Induces Apoptosis in Activated Lymphocytes and Ameliorates Concanavalin A-Induced Hepatitis in Mice
por: Zhang, Yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_70c5euu06596o20441ev3iu8fa